Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.0168
|
0.037
|
0.0156
|
0.0156
|
0.0156
|
0.0156
|
|
|
|
|
0.0164
|
0.0366
|
0.0156
|
0.0156
|
0.0156
|
0.0156
|
|
|
|
|
0.0154
|
0.0356
|
0.0142
|
0.0142
|
0.0142
|
0.0142
|
|
|
|
|
0.0142
|
0.0344
|
0.0152
|
0.0152
|
0.0152
|
0.0152
|
|
|
|
|
0.0152
|
0.0354
|
0.0148
|
0.0148
|
0.0148
|
0.0148
|
|
|
|
|
0.0148
|
0.035
|
0.014
|
0.014
|
0.014
|
0.014
|
|
|
|
|
0.014
|
0.0342
|
0.0138
|
0.0138
|
0.0138
|
0.0138
|
|
|
|
|
0.0138
|
0.034
|
0.0132
|
0.0132
|
0.0132
|
0.0132
|
|
|
|
|
0.0132
|
0.0334
|
0.0132
|
0.0132
|
0.0132
|
0.0132
|
|
|
|
|
0.013
|
0.0332
|
0.0132
|
0.0132
|
0.0132
|
0.0132
|
|
|
|
|
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.